Ibritumomab Intravenous and MorphaBond ER
Determining the interaction of Ibritumomab Intravenous and MorphaBond ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphabond ER
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Morphine
- Ibritumomab Intravenous-Morphine (Systemic)
- Ibritumomab Intravenous-Morphine and naltrexone
- Ibritumomab Intravenous-Morphine Epidural
- Ibritumomab Intravenous-Morphine ER
- Ibritumomab Intravenous-Morphine Extended-Release Capsules
- MorphaBond ER-Ibritumomab Tiuxetan
- MorphaBond ER-Ibrutinib
- MorphaBond ER-Ibrutinib Capsules
- MorphaBond ER-Ibrutinib Tablets
- MorphaBond ER-Ibu
- MorphaBond ER-IBU Tablets